Bay­er fol­lows No­var­tis' foot­steps in ink­ing ra­dio­phar­ma pact with Bi­cy­cle, pay­ing $45M cash up­front

Bay­er is en­list­ing Bi­cy­cle Ther­a­peu­tics on the cre­ation of new tar­get­ed ra­dio­ther­a­pies — and it’s hand­ing over $45 mil­lion in cash to get things start­ed. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER